REFERENCES
- Degenhardt L, Hall W, Warner-Smith M. Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS. Sex Transm Infect 2006; 82:iii56–63.
- Bargagli AM, Hickman M, Davoli M, Perucci CA, Schifano P, Buster M, Brugal T, Vicente J. COSMO European Group. Drug-related mortality and its impact on adult mortality in eight European countries. Eur J Public Health 2006; 16:198–202.
- Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med 2005; 6:99–106.
- Darke S, Zador D. Fatal heroin ‘overdose’: A review. Addiction 1996; 91:1765–1772.
- Miller CL, Kerr T, Strathdee SA, Li K, Wood E. Factors associated with premature mortality among young injection drug users in Vancouver. Harm Reduct J 2007; 4:1.
- Ribeiro M, Dunn J, Sesso R, Dias AC, Laranjeira R. Causes of death among crack cocaine users. Rev Bras Psiquiatr 2006; 28:196–202.
- Pollini RA, McCall L, Mehta SH, Celentano DD, Vlahov D, Strathdee SA. Response to overdose among injection drug users. Am J Prev Med 2006; 31:261–264.
- McGregor C, Darke S, Ali R, Christie P. Experience of non-fatal overdose among heroin users in Adelaide, Australia: Circumstances and risk perceptions. Addiction 1998; 93:701–711.
- Heale P, Dietze P, Fry C. Deliberate overdose among heroin overdose survivors. J Urban Health 2003; 80:230–237.
- Darke S, Williamson A, Ross J, Mills KL, Havard A, Teesson M. Patterns of nonfatal heroin overdose over a 3-Year period: Findings from the Australian treatment outcome study. J Urban Health 2007; 84:283–291.
- Sergeev B, Karpets A, Sarang A, Tikhonov M. Prevalence and circumstances of opiate overdose among injection drug users in the Russian Federation. J Urban Health 2003; 80:212–219.
- Aceijas C, Stimson GV, Hickman M, Rhodes T; United Nations Reference Group on HIV/AIDS Prevention and Care among IDU in Developing and Transitional Countries. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 2004; 18:2295–2303.
- Chu TX, Levy JA. Injection drug use and HIV/AIDS transmission in China. Cell Res 2005; 15:865–869.
- Lu F, Wang N, Wu Z, Sun X, Rehnstrom J, Poundstone K, Yu W, Pisani E. Estimating the number of people at risk for and living with HIV in China in 2005: Methods and results. Sex Transm Infect 2006; 82:iii87–iii91.
- Qian HZ, Schumacher JE, Chen HT, Ruan YH. Injection drug use and HIV/AIDS in China: Review of current situation, prevention and policy implications. Harm Reduct J 2006; 3:4.
- Zhang L, Ruan YH, Jiang ZQ, Yang ZN, Liu SZ, Zhou F, He YX, Yin L, Qin GM, Shao YM. A 1-year prospective cohort study on mortality of injecting drug users. Zhong Hua Liu Xing Bing Xue Za Zhi 2005; 26:190–193.
- Gossop M, Griffiths P, Powis B, Williamson S, Strang J. Frequency of non-fatal heroin overdose: Survey of heroin users recruited in non-clinical settings. BMJ 1996; 313:402.
- Powis B, Strang J, Griffiths P, Taylor C, Williamson S, Fountain J, Gossop M. Self-reported overdose among injecting drug users in London: Extent and nature of the problem. Addiction 1999; 94:471–478.
- Pollini RA, McCall L, Mehta SH, Vlahov D, Strathdee SA. Non-fatal overdose and subsequent drug treatment among injection drug users. Drug Alcohol Depend 2006; 83:104–110.
- Seal KH, Kral AH, Gee L, Moore LD, Bluthenthal RN, Lorvick J, Edlin BR. Predictors and Prevention of Nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998–1999. Am J Public Health 2001; 91:1842–1846.
- Sergeev B, Karpets A, Sarang A, Tikhonov M. Prevalence and circumstances of opiate overdose among injection drug users in the Russian Federation. J Urban Health 2003; 80:212–9.
- Sporer KA, Kral AH. Prescription naloxone: Novel approach to heroin overdose prevention. Ann Emerg Med 2007; 49:172–7.
- Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: I. prevalence and correlates of non-fatal overdose. Addiction 1996; 91:405–411.
- Brugal MT, Barrio G, De LF, Regidor E, Royuela L, Suelves JM. Factors associated with non-fatal heroin overdose: Assessing the effect of frequency and route of heroin administration. Addiction 2002; 97:319–327.
- Darke S, Hall W, Weatherburn D, Lind B. Fluctuations in heroin purity and the incidence of fatal heroin overdose. Drug Alcohol Depend 1999; 54:155–161.
- Odegard E, Amundsen EJ, Kielland KB. Fatal overdoses and deaths by other causes in a cohort of Norwegian drug abusers-A competing risk approach. Drug Alcohol Depend 2007; 89:176–182.
- Stewart D, Gossop M, Marsden J. Reductions in non-fatal overdose after drug misuse treatment: Results from the National Treatment Outcome Research Study (NTORS). J Subst Abuse Treat 2002; 22:1–9.
- O'Driscoll PT, McGough J, Hagan H, Thiede H, Critchlow C, Alexander ER. Predictors of accidental fatal drug overdose among a cohort of injection drug users. Am J Public Health 2001; 91:984–987.
- Brugal MT, Domingo-Salvany A, Puig R, Barrio G, Garcia de Olalla P, de la Fuente L. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction 2005; 100:981–989.
- Davoli M, Perucci CA, Forastiere F, Doyle P, Rapiti E, Zaccarelli M, Abeni DD. Risk factors for overdose mortality: A case-control study within a cohort of intravenous drug users. Int J Epidemiol 1993; 22:273–277.
- Lugo RA, Satterfield KL, Kern SE. Pharmacokinetics of methadone. J Pain Palliat Care Pharmacother 2005; 19:13–24.